Literature DB >> 30718280

The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Johanna Bialas1,2, Annika N Boehm1,2, Nicola Catone2, Annette Aichem3,2, Marcus Groettrup1,2.   

Abstract

The deubiquitylation of target proteins is mediated by deubiquitylating enzymes (DUB) such as OTUB1, which plays an important role in immune response, cell cycle progression, and DNA repair. Within these processes, OTUB1 reduces the ubiquitylation of target proteins in two distinct ways, either by using its catalytic DUB activity or in a noncatalytic manner by inhibiting the E2-conjugating enzyme. Here, we show that the ubiquitin-like modifier FAT10 regulates OTUB1 stability and functionality in different ways. Covalent FAT10ylation of OTUB1 resulted in its proteasomal degradation, whereas a noncovalent interaction stabilized OTUB1. We provide evidence that OTUB1 interacts directly with FAT10 and the E2-conjugating enzyme USE1. This interaction strongly stimulated OTUB1 DUB activity toward Lys-48-linked diubiquitin. Furthermore, the noncovalent interaction between FAT10 and OTUB1 not only enhanced its isopeptidase activity toward Lys-48-linked ubiquitin moieties but also strengthened its noncatalytic activity in reducing Lys-63 polyubiquitylation of its target protein TRAF3 (TNF receptor-associated factor 3). Additionally, the cellular clearance of overall polyubiquitylation by OTUB1 was strongly stimulated through the presence of FAT10. The addition of FAT10 also led to an increased interaction between OTUB1 and its cognate E2 UbcH5B, implying a function of FAT10 in the inhibition of polyubiquitylation. Overall, these data indicate that FAT10 not only plays a role in covalent modification, leading its substrates to proteasomal degradation, but also regulates the stability and functionality of target proteins by interacting in a noncovalent manner. FAT10 is thereby able to exert a major influence on ubiquitylation processes.
© 2019 Bialas et al.

Entities:  

Keywords:  FAT10; USE1; enzyme activity; inflammation; proteasome; ubiquitin; ubiquitin thioesterase (OTUB1); ubiquitin-conjugating enzyme (E2 enzyme); ubiquitin-like protein; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2019        PMID: 30718280      PMCID: PMC6433071          DOI: 10.1074/jbc.RA118.005406

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Detection and analysis of FAT10 modification.

Authors:  Annette Aichem; Marcus Groettrup
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Ubiquitin-like proteins.

Authors:  Annemarthe G van der Veen; Hidde L Ploegh
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

3.  Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion.

Authors:  Mariola J Edelmann; Holger B Kramer; Mikael Altun; Benedikt M Kessler
Journal:  FEBS J       Date:  2010-06       Impact factor: 5.542

4.  Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1.

Authors:  Shinichiro Nakada; Ikue Tai; Stephanie Panier; Abdallah Al-Hakim; Shun-Ichiro Iemura; Yu-Chi Juang; Lara O'Donnell; Ayako Kumakubo; Meagan Munro; Frank Sicheri; Anne-Claude Gingras; Tohru Natsume; Toshio Suda; Daniel Durocher
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 5.  The ubiquitin-like modifier FAT10 in cancer development.

Authors:  Annette Aichem; Marcus Groettrup
Journal:  Int J Biochem Cell Biol       Date:  2016-07-05       Impact factor: 5.085

6.  UBE1L2, a novel E1 enzyme specific for ubiquitin.

Authors:  Christiane Pelzer; Ingrid Kassner; Konstantin Matentzoglu; Rajesh K Singh; Hans-Peter Wollscheid; Martin Scheffner; Gunter Schmidtke; Marcus Groettrup
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

7.  FAT10 Is Critical in Influenza A Virus Replication by Inhibiting Type I IFN.

Authors:  Yanli Zhang; Jun Tang; Ning Yang; Qiang Liu; Qingchao Zhang; Yanxu Zhang; Ning Li; Yan Zhao; Shunwang Li; Song Liu; Huandi Zhou; Xiao Li; Mingyao Tian; Jiejie Deng; Peng Xie; Yang Sun; Huijun Lu; Michael Q Zhang; Ningyi Jin; Chengyu Jiang
Journal:  J Immunol       Date:  2016-06-27       Impact factor: 5.422

8.  Disruption of FAT10-MAD2 binding inhibits tumor progression.

Authors:  Steven Setiawan Theng; Wei Wang; Way-Champ Mah; Cheryl Chan; Jingli Zhuo; Yun Gao; Haina Qin; Liangzhong Lim; Samuel S Chong; Jianxing Song; Caroline G Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

9.  A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha.

Authors:  S Raasi; G Schmidtke; R de Giuli; M Groettrup
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

10.  HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1.

Authors:  Yanyan Peng; Ruidan Xu; Xiaofeng Zheng
Journal:  PLoS Pathog       Date:  2014-04-24       Impact factor: 6.823

View more
  7 in total

1.  The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.

Authors:  Annika N Boehm; Johanna Bialas; Nicola Catone; Almudena Sacristan-Reviriego; Jacqueline van der Spuy; Marcus Groettrup; Annette Aichem
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

2.  FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression.

Authors:  Jinfeng Zhu; Jiefeng Zhao; Chen Luo; Zhengming Zhu; Xingyu Peng; Xiaojian Zhu; Kang Lin; Fanqin Bu; Wenjun Zhang; Qing Li; Kai Wang; Zhigang Hu; Xin Yu; Leifeng Chen; Rongfa Yuan
Journal:  Cell Death Dis       Date:  2022-05-25       Impact factor: 9.685

3.  The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Atsuko Sugimoto; Yuichi Abe; Tadashi Watanabe; Kohei Hosokawa; Jun Adachi; Takeshi Tomonaga; Yasumasa Iwatani; Takayuki Murata; Masahiro Fujimuro
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

Review 4.  Regulation of Interferon Induction by the Ubiquitin-Like Modifier FAT10.

Authors:  Mei Min Mah; Nicola Roverato; Marcus Groettrup
Journal:  Biomolecules       Date:  2020-06-23

5.  The ubiquitin-like modifier FAT10 interferes with SUMO activation.

Authors:  Annette Aichem; Carolin Sailer; Stella Ryu; Nicola Catone; Nicolas Stankovic-Valentin; Gunter Schmidtke; Frauke Melchior; Florian Stengel; Marcus Groettrup
Journal:  Nat Commun       Date:  2019-10-01       Impact factor: 14.919

Review 6.  UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.

Authors:  Fengting Wang; Bo Zhao
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

7.  Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling.

Authors:  An Song; Yi Wang; Feng Jiang; Enshi Yan; Junbo Zhou; Jinhai Ye; Hongchuang Zhang; Xu Ding; Gang Li; Yunong Wu; Yang Zheng; Xiaomeng Song
Journal:  Mol Cells       Date:  2021-07-31       Impact factor: 5.034

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.